SNDLSNDL Inc

NASDAQ · Pharmaceuticals · Pharmaceuticals

$1.51-11.18%Market cap352.51M
Latest Close
$1.51
30-Day Move
-11.2%
Market Cap
$353M
Shares Outstanding
257,400,000
P/B Ratio
0.54
ROE
-1.4%

Analyst consensus: Buy · 8 analysts

NASDAQ:SNDLPharmaceuticals / PharmaceuticalsDelayed public snapshot

SNDL Inc

A read-only Alphactor snapshot forSNDL Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.

Snapshot as of2026-04-21

Topline snapshot

Latest Close

$1.51

30-Day Move

-11.2%

Market Cap

$353M

Shares Outstanding

257,400,000

P/B Ratio

0.54

ROE

-1.4%

Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot

$1.51

-11.2%last 90 delayed daily bars

Market cap$353M

90D High

$2.34

90D Low

$1.28

Avg Volume

2,258,701

What stands out

Gross margin is running at 27.3%, which gives a quick read on operating quality before you open the full model.

Net margin is -1.7%, useful for comparing SNDL against peers in Pharmaceuticals.

SNDL is down 11.2% over the last 30 trading days shown on this page.

Latest operating income is $10M, which helps anchor the headline ratios with an actual earnings figure.

Research snapshot

Composite Fair Value

$11.38

Rule of 40

9.0%

Dark Pool Short %

23.4%

Fundamentals snapshot

Latest Close

$1.51

30-Day Move

-11.2%

Market Cap

$353M

Shares Outstanding

257,400,000

P/B Ratio

0.54

ROE

-1.4%

ROA

-1.2%

Gross Margin

27.3%

Operating Margin

-85.0%

Net Margin

-1.7%

Debt / Equity

0.15

Current Ratio

4.88

Latest Revenue

$252M

Financial statement snapshot

Revenue

$252M

Gross Profit

$70M

Operating Income

$10M

Net Income

$9M

Gross Margin

2733.0%

Net Margin

-167.0%

Current Ratio

4.88

Debt / Equity

0.15

Valuation snapshot

Fair Value

$11.38

Upside / Downside

+653.9%

Signal

Undervalued

Implied Growth

-12.3%

DCF

$4.07

EV/Rev

$18.70

Growth Assumption

9.9%

Discount Rate

10.5%

Terminal Growth

2.0%

Base FCF

$58M

Valuation spread

Current Price
$1.51
Composite Fair Value
$11.38
DCF
$4.07
EV/Rev
$18.70

After signup

The full valuation workspace goes deeper

Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.

Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.

Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.

Sign up to open the valuation workspace

Negative growth / decline priced in

Quality snapshot

Altman Z

0.55

Distress

Piotroski

6

Moderate (4-6)

Cash Conversion

-4.50x

Rule of 40

9.0%

Concerning

Annual financial history

Annual performance mix

PeriodRevenueOperating IncomeNet IncomeFree Cash Flow
2022-12-31$712M$-61M$-335M$-18M
2023-12-31$909M$-100M$-173M$-25M
2024-12-31$920M$-34M$-95M$44M
2025-12-31$946M$-4M$-16M$58M

After signup

The app opens the full statement deep dive

Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.

Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.

Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.

Sign up to open the full statements
News snapshot

After signup

The full sentiment workspace adds context

Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.

Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.

Sign up to open the full news feed
ETF holders snapshot
ETFSharesWeightAs Of
Amplify ETF Trust-Amplify Alternative Harvest ETF4,970,3420.02%2025-12-31
AdvisorShares Trust-AdvisorShares Pure US Cannabis ETF2,580,9760.01%2026-02-28
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF1,012,6450.00%2026-02-28
Cambria ETF Trust-Cambria Cannabis ETF352,8420.00%2026-03-31
SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Developed World ex-US E290,4230.00%2026-02-28
Amplify ETF Trust-Amplify Seymour Cannabis ETF203,5560.00%2025-12-31
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.172,4380.00%2026-01-31
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund164,9000.00%2026-02-28

After signup

The deeper ownership view shows who is leaning in

Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.

Use those ownership shifts alongside conviction and alerts in the full app workflow.

Sign up to open holder detail
Institutional holders snapshot

Invesco

Filed 2026-02-19

--

--

Citadel Advisors

Filed 2025-11-14

$6M

--

Goldman Sachs

Filed 2026-02-10

$2M

+40.8%

Man Group

Filed 2025-11-14

$1M

--

Qube Research & Technologies

Filed 2026-02-17

$1M

+103.1%

Dark-pool activity snapshot
Analyst consensus?
Rating(?)

4.13

Consensus

Buy
Target Mean(?)

Target High(?)

Target Low(?)

Analysts

8

Premium previews

See where the deeper analysis goes next

Sign up free
Open a preview card to sample a premium module.

High-intent actions

What you can do after signup

Organic traffic stays on the free tier by default, but signing up lets you save work and continue exploring.

For informational and educational purposes only. Not financial advice. Learn more

For informational and educational purposes only. Not financial advice. Learn more